Annual accounts receivable:
$10.28B-$71.00M(-0.69%)Summary
- As of today (May 21, 2025), MRK annual accounts receivable is $10.28 billion, with the most recent change of -$71.00 million (-0.69%) on December 31, 2024.
- During the last 3 years, MRK annual accounts receivable has risen by +$1.05 billion (+11.35%).
- MRK annual accounts receivable is now -0.69% below its all-time high of $10.35 billion, reached on December 31, 2023.
Performance
MRK Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$10.79B+$512.00M(+4.98%)Summary
- As of today (May 21, 2025), MRK quarterly accounts receivable is $10.79 billion, with the most recent change of +$512.00 million (+4.98%) on March 1, 2025.
- Over the past year, MRK quarterly accounts receivable has dropped by -$576.00 million (-5.07%).
- MRK quarterly accounts receivable is now -7.32% below its all-time high of $11.64 billion, reached on June 30, 2024.
Performance
MRK Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
MRK Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.7% | -5.1% |
| 3 y3 years | +11.3% | +9.8% |
| 5 y5 years | +51.6% | +31.9% |
MRK Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.7% | +11.3% | -7.3% | +14.2% |
| 5 y | 5-year | -0.7% | +51.6% | -7.3% | +58.6% |
| alltime | all time | -0.7% | +253.5% | -7.3% | +271.1% |
MRK Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $10.79B(+5.0%) |
| Dec 2024 | $10.28B(-0.7%) | $10.28B(-9.7%) |
| Sep 2024 | - | $11.38B(-2.2%) |
| Jun 2024 | - | $11.64B(+2.4%) |
| Mar 2024 | - | $11.37B(+9.8%) |
| Dec 2023 | $10.35B(+9.5%) | $10.35B(-0.4%) |
| Sep 2023 | - | $10.39B(-5.8%) |
| Jun 2023 | - | $11.03B(+5.9%) |
| Mar 2023 | - | $10.41B(+10.2%) |
| Dec 2022 | $9.45B(+2.4%) | $9.45B(-0.3%) |
| Sep 2022 | - | $9.48B(-1.7%) |
| Jun 2022 | - | $9.64B(-1.9%) |
| Mar 2022 | - | $9.83B(+6.5%) |
| Dec 2021 | $9.23B(+35.7%) | $9.23B(+7.7%) |
| Sep 2021 | - | $8.57B(+9.3%) |
| Jun 2021 | - | $7.84B(-4.8%) |
| Mar 2021 | - | $8.23B(+21.0%) |
| Dec 2020 | $6.80B(+0.4%) | $6.80B(-19.2%) |
| Sep 2020 | - | $8.42B(+11.2%) |
| Jun 2020 | - | $7.58B(-7.4%) |
| Mar 2020 | - | $8.18B(+20.7%) |
| Dec 2019 | $6.78B(-4.1%) | $6.78B(-19.7%) |
| Sep 2019 | - | $8.44B(+6.0%) |
| Jun 2019 | - | $7.96B(+4.7%) |
| Mar 2019 | - | $7.61B(+7.6%) |
| Dec 2018 | $7.07B(+2.9%) | $7.07B(-4.1%) |
| Sep 2018 | - | $7.37B(+1.2%) |
| Jun 2018 | - | $7.29B(+0.6%) |
| Mar 2018 | - | $7.25B(+5.4%) |
| Dec 2017 | $6.87B(-2.1%) | $6.87B(-10.4%) |
| Sep 2017 | - | $7.67B(+3.1%) |
| Jun 2017 | - | $7.44B(+5.3%) |
| Mar 2017 | - | $7.07B(+0.7%) |
| Dec 2016 | $7.02B(+8.2%) | $7.02B(-4.7%) |
| Sep 2016 | - | $7.36B(+6.5%) |
| Jun 2016 | - | $6.92B(+1.0%) |
| Mar 2016 | - | $6.85B(+5.6%) |
| Dec 2015 | $6.48B(-2.1%) | $6.48B(+1.1%) |
| Sep 2015 | - | $6.41B(-1.5%) |
| Jun 2015 | - | $6.51B(-2.4%) |
| Mar 2015 | - | $6.67B(+0.7%) |
| Dec 2014 | $6.63B(-7.8%) | $6.63B(+1.7%) |
| Sep 2014 | - | $6.51B(-7.2%) |
| Jun 2014 | - | $7.02B(-2.3%) |
| Mar 2014 | - | $7.19B(+0.1%) |
| Dec 2013 | $7.18B(-6.4%) | $7.18B(-5.2%) |
| Sep 2013 | - | $7.58B(-2.6%) |
| Jun 2013 | - | $7.78B(-2.3%) |
| Mar 2013 | - | $7.96B(+3.8%) |
| Dec 2012 | $7.67B | $7.67B(-3.5%) |
| Sep 2012 | - | $7.95B(-2.5%) |
| Jun 2012 | - | $8.15B(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $8.73B(+5.6%) |
| Dec 2011 | $8.26B(+12.5%) | $8.26B(+1.5%) |
| Sep 2011 | - | $8.14B(-4.0%) |
| Jun 2011 | - | $8.47B(+6.5%) |
| Mar 2011 | - | $7.96B(+8.3%) |
| Dec 2010 | $7.34B(+11.2%) | $7.34B(+17.0%) |
| Jun 2010 | - | $6.28B(-16.3%) |
| Mar 2010 | - | $7.50B(+13.5%) |
| Dec 2009 | $6.60B(+127.1%) | $6.60B(+73.6%) |
| Sep 2009 | - | $3.80B(+3.8%) |
| Jun 2009 | - | $3.66B(+2.6%) |
| Mar 2009 | - | $3.57B(+22.8%) |
| Dec 2008 | $2.91B(-20.0%) | $2.91B(-20.2%) |
| Sep 2008 | - | $3.64B(-0.1%) |
| Jun 2008 | - | $3.65B(-3.0%) |
| Mar 2008 | - | $3.76B(+3.4%) |
| Dec 2007 | $3.64B(+9.7%) | $3.64B(+3.8%) |
| Sep 2007 | - | $3.50B(-2.9%) |
| Jun 2007 | - | $3.61B(-10.2%) |
| Mar 2007 | - | $4.02B(+21.2%) |
| Dec 2006 | $3.31B(+13.2%) | $3.31B(+7.6%) |
| Sep 2006 | - | $3.08B(-0.1%) |
| Jun 2006 | - | $3.08B(+1.4%) |
| Mar 2006 | - | $3.04B(+3.9%) |
| Dec 2005 | $2.93B(-19.3%) | $2.93B(-19.7%) |
| Sep 2005 | - | $3.65B(+4.0%) |
| Jun 2005 | - | $3.51B(-7.7%) |
| Mar 2005 | - | $3.80B(+4.7%) |
| Dec 2004 | $3.63B(-9.8%) | $3.63B(-7.2%) |
| Sep 2004 | - | $3.91B(+0.5%) |
| Jun 2004 | - | $3.89B(-7.4%) |
| Mar 2004 | - | $4.20B(+4.4%) |
| Dec 2003 | $4.02B(-25.8%) | $4.02B(-11.8%) |
| Sep 2003 | - | $4.56B(-22.7%) |
| Jun 2003 | - | $5.90B(+5.1%) |
| Mar 2003 | - | $5.62B(+3.6%) |
| Dec 2002 | $5.42B(+4.0%) | $5.42B(-1.8%) |
| Sep 2002 | - | $5.52B(-4.5%) |
| Jun 2002 | - | $5.79B(+4.0%) |
| Mar 2002 | - | $5.57B(+6.7%) |
| Dec 2001 | $5.22B(+3.9%) | $5.22B(-5.7%) |
| Sep 2001 | - | $5.53B(+5.4%) |
| Jun 2001 | - | $5.25B(+4.8%) |
| Mar 2001 | - | $5.01B(-0.2%) |
| Dec 2000 | $5.02B(+22.7%) | $5.02B(+9.8%) |
| Sep 2000 | - | $4.57B(+18.3%) |
| Jun 2000 | - | $3.86B(+4.6%) |
| Mar 2000 | - | $3.69B(-9.7%) |
| Dec 1999 | $4.09B(+21.2%) | $4.09B(+16.9%) |
| Sep 1999 | - | $3.50B(+3.5%) |
| Jun 1999 | - | $3.38B(+7.9%) |
| Mar 1999 | - | $3.13B(-7.2%) |
| Dec 1998 | $3.37B | $3.37B |
FAQ
- What is Merck & Co annual accounts receivable?
- What is the all time high annual accounts receivable for Merck & Co?
- What is Merck & Co annual accounts receivable year-on-year change?
- What is Merck & Co quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Merck & Co?
- What is Merck & Co quarterly accounts receivable year-on-year change?
What is Merck & Co annual accounts receivable?
The current annual accounts receivable of MRK is $10.28B
What is the all time high annual accounts receivable for Merck & Co?
Merck & Co all-time high annual accounts receivable is $10.35B
What is Merck & Co annual accounts receivable year-on-year change?
Over the past year, MRK annual accounts receivable has changed by -$71.00M (-0.69%)
What is Merck & Co quarterly accounts receivable?
The current quarterly accounts receivable of MRK is $10.79B
What is the all time high quarterly accounts receivable for Merck & Co?
Merck & Co all-time high quarterly accounts receivable is $11.64B
What is Merck & Co quarterly accounts receivable year-on-year change?
Over the past year, MRK quarterly accounts receivable has changed by -$576.00M (-5.07%)